Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Chronic Heart Failure

  Free Subscription


Articles published in Am Heart J

Retrieve available abstracts of 89 articles:
HTML format
Text format



Single Articles


    March 2017
  1. KUPSKY DF, Ahmed AM, Sakr S, Qureshi WT, et al
    Cardiorespiratory fitness and incident heart failure: The Henry Ford ExercIse Testing (FIT) Project.
    Am Heart J. 2017;185:35-42.
    PubMed     Text format     Abstract available


  2. REEVES GR, Whellan DJ, Duncan P, O'Connor CM, et al
    Rehabilitation Therapy in Older Acute Heart Failure Patients (REHAB-HF) trial: Design and rationale.
    Am Heart J. 2017;185:130-139.
    PubMed     Text format     Abstract available


    January 2017
  3. VERMA AK, Schulte PJ, Bittner V, Keteyian SJ, et al
    Socioeconomic and partner status in chronic heart failure: Relationship to exercise capacity, quality of life, and clinical outcomes.
    Am Heart J. 2017;183:54-61.
    PubMed     Text format     Abstract available


  4. COX ZL, Lewis CM, Lai P, Lenihan DJ, et al
    Validation of an automated electronic algorithm and "dashboard" to identify and characterize decompensated heart failure admissions across a medical center.
    Am Heart J. 2017;183:40-48.
    PubMed     Text format     Abstract available


  5. NAGARAJAN V, Hernandez AV, Cauthen CA, Starling RC, et al
    Usefulness of cell-mediated immune function in risk stratification for patients with advanced heart failure.
    Am Heart J. 2017;183:35-39.
    PubMed     Text format     Abstract available


  6. STEINHAUS DA, Mostofsky E, Levitan EB, Dorans KS, et al
    Chocolate intake and incidence of heart failure: Findings from the Cohort of Swedish Men.
    Am Heart J. 2017;183:18-23.
    PubMed     Text format     Abstract available


  7. THIBODEAU JT, Jenny BE, Maduka JO, Divanji PH, et al
    Bendopnea and risk of adverse clinical outcomes in ambulatory patients with systolic heart failure.
    Am Heart J. 2017;183:102-107.
    PubMed     Text format     Abstract available


    December 2016
  8. ECHOUFFO-TCHEUGUI JB, Xu H, DeVore AD, Schulte PJ, et al
    Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: Findings from Get With The Guidelines-Heart Failure registry.
    Am Heart J. 2016;182:9-20.
    PubMed     Text format     Abstract available


  9. SPITZER E, Van Mieghem NM, Pibarot P, Hahn RT, et al
    Rationale and design of the Transcatheter Aortic Valve Replacement to UNload the Left ventricle in patients with ADvanced heart failure (TAVR UNLOAD) trial.
    Am Heart J. 2016;182:80-88.
    PubMed     Text format     Abstract available


    November 2016
  10. LEE DS, Lee JS, Schull MJ, Grimshaw JM, et al
    Design and rationale for the Acute Congestive Heart Failure Urgent Care Evaluation: The ACUTE Study.
    Am Heart J. 2016;181:60-65.
    PubMed     Text format     Abstract available


    September 2016
  11. THUNE JJ, Pehrson S, Nielsen JC, Haarbo J, et al
    Rationale, design, and baseline characteristics of the DANish randomized, controlled, multicenter study to assess the efficacy of Implantable cardioverter defibrillators in patients with non-ischemic Systolic Heart failure on mortality (DANISH).
    Am Heart J. 2016;179:136-41.
    PubMed     Text format     Abstract available


  12. GILOTRA NA, Bennett MK, Shpigel A, Ahmed HM, et al
    Outcomes and predictors of recovery in acute-onset cardiomyopathy: A single-center experience of patients undergoing endomyocardial biopsy for new heart failure.
    Am Heart J. 2016;179:116-26.
    PubMed     Text format     Abstract available


  13. SHREIBATI JB, Sheng S, Fonarow GC, DeVore AD, et al
    Heart failure medications prescribed at discharge for patients with left ventricular assist devices.
    Am Heart J. 2016;179:99-106.
    PubMed     Text format     Abstract available


  14. YAZDAN-ASHOORI P, Lee SF, Ibrahim Q, Van Spall HG, et al
    Utility of the LACE index at the bedside in predicting 30-day readmission or death in patients hospitalized with heart failure.
    Am Heart J. 2016;179:51-8.
    PubMed     Text format     Abstract available


    August 2016
  15. DEVORE AD, Greiner MA, Sharma PP, Qualls LG, et al
    Development and validation of a risk model for in-hospital worsening heart failure from the Acute Decompensated Heart Failure National Registry (ADHERE).
    Am Heart J. 2016;178:198-205.
    PubMed     Text format     Abstract available


  16. ALLEN LA, McIlvennan CK
    Predicting in-hospital worsening heart failure at time of admission, but do we really need another heart failure risk model?
    Am Heart J. 2016;178:188-9.
    PubMed     Text format    


  17. MALEBRANCHE R, Tabou Moyo C, Morisset PH, Raphael NA, et al
    Clinical and echocardiographic characteristics and outcomes in congestive heart failure at the Hospital of The State University of Haiti.
    Am Heart J. 2016;178:151-60.
    PubMed     Text format     Abstract available


  18. PAINE NJ, Hinderliter AL, Blumenthal JA, Adams KF Jr, et al
    Reactive hyperemia is associated with adverse clinical outcomes in heart failure.
    Am Heart J. 2016;178:108-14.
    PubMed     Text format     Abstract available


  19. FROHLICH H, Nelges C, Tager T, Schwenger V, et al
    Long-term changes of renal function in relation to ace inhibitor/angiotensin receptor blocker dosing in patients with heart failure and chronic kidney disease.
    Am Heart J. 2016;178:28-36.
    PubMed     Text format     Abstract available


    May 2016
  20. PAPADIMITRIOU L, Smith-Jones PM, Sarwar CM, Marti CN, et al
    Utility of positron emission tomography for drug development for heart failure.
    Am Heart J. 2016;175:142-52.
    PubMed     Text format     Abstract available


    April 2016
  21. SHAFIQ A, Brawner CA, Aldred HA, Lewis B, et al
    Prognostic value of cardiopulmonary exercise testing in heart failure with preserved ejection fraction. The Henry Ford HospITal CardioPulmonary EXercise Testing (FIT-CPX) project.
    Am Heart J. 2016;174:167-72.
    PubMed     Text format     Abstract available


  22. GUAZZI M
    Cardiopulmonary exercise testing in heart failure preserved ejection fraction: Time to expand the paradigm in the prognostic algorithm.
    Am Heart J. 2016;174:164-6.
    PubMed     Text format    


  23. AXON RN, Gebregziabher M, Everett CJ, Heidenreich P, et al
    Dual health care system use is associated with higher rates of hospitalization and hospital readmission among veterans with heart failure.
    Am Heart J. 2016;174:157-63.
    PubMed     Text format     Abstract available


  24. DESAI NR
    Toward evidence-based health care delivery reform.
    Am Heart J. 2016;174:154-6.
    PubMed     Text format    


    March 2016
  25. DEVORE AD, Mi X, Mentz RJ, Fonarow GC, et al
    Discharge heart rate and beta-blocker dose in patients hospitalized with heart failure: Findings from the OPTIMIZE-HF registry.
    Am Heart J. 2016;173:172-8.
    PubMed     Text format     Abstract available


  26. COLE RT
    Making a case for ivabradine: Should we SHIFT our focus to OPTIMIZE outcomes?
    Am Heart J. 2016;173:170-1.
    PubMed     Text format    


    February 2016
  27. ABOUEZZEDDINE OF, Lala A, Khazanie PP, Shah R, et al
    Evaluation of a provocative dyspnea severity score in acute heart failure.
    Am Heart J. 2016;172:34-41.
    PubMed     Text format     Abstract available


    January 2016
  28. SHIRAISHI Y, Kohsaka S, Abe T, Mizuno A, et al
    Validation of the Get With The Guideline-Heart Failure risk score in Japanese patients and the potential improvement of its discrimination ability by the inclusion of B-type natriuretic peptide level.
    Am Heart J. 2016;171:33-9.
    PubMed     Text format     Abstract available


    December 2015
  29. COOPER LB, Hammill BG, Sharma PP, DeVore AD, et al
    Differences in health care use and outcomes by the timing of in-hospital worsening heart failure.
    Am Heart J. 2015;170:1124-32.
    PubMed     Text format     Abstract available


  30. VAKIL KP, Roukoz H, Tung R, Levy WC, et al
    Mortality prediction using a modified Seattle Heart Failure Model may improve patient selection for ventricular tachycardia ablation.
    Am Heart J. 2015;170:1099-104.
    PubMed     Text format     Abstract available


    November 2015
  31. FISCHER C, Steyerberg EW, Fonarow GC, Ganiats TG, et al
    A systematic review and meta-analysis on the association between quality of hospital care and readmission rates in patients with heart failure.
    Am Heart J. 2015;170:1005-1017.
    PubMed     Text format     Abstract available


  32. GILSTRAP LG, Joynt KE
    Both processes and readmissions matter for heart failure: How can we align them?
    Am Heart J. 2015;170:968-70.
    PubMed     Text format    


  33. LAZO M, Halushka MK, Shen L, Maruthur N, et al
    Soluble receptor for advanced glycation end products and the risk for incident heart failure: The Atherosclerosis Risk in Communities Study.
    Am Heart J. 2015;170:961-7.
    PubMed     Text format     Abstract available


  34. REED SD, Neilson MP, Gardner M, Li Y, et al
    Tools for Economic Analysis of Patient Management Interventions in Heart Failure Cost-Effectiveness Model: A Web-based program designed to evaluate the cost-effectiveness of disease management programs in heart failure.
    Am Heart J. 2015;170:951-60.
    PubMed     Text format     Abstract available


  35. SNIPELISKY D, Stulak JM, Schettle SD, Sharma S, et al
    Psychosocial characteristics and outcomes in patients with left ventricular assist device implanted as destination therapy.
    Am Heart J. 2015;170:887-94.
    PubMed     Text format     Abstract available


    October 2015
  36. DOKAINISH H, Teo K, Zhu J, Roy A, et al
    Heart failure in low- and middle-income countries: Background, rationale, and design of the INTERnational Congestive Heart Failure Study (INTER-CHF).
    Am Heart J. 2015;170:627-634.
    PubMed     Text format     Abstract available


    September 2015
  37. CHAUHAN V, Dev S, Pham M, Lin S, et al
    Facility variation and predictors of serum potassium monitoring after initiation of a mineralocorticoid receptor antagonist in patients with heart failure.
    Am Heart J. 2015;170:543-9.
    PubMed     Text format     Abstract available


  38. SALAH K, Pinto YM, Eurlings LW, Metra M, et al
    Serum potassium decline during hospitalization for acute decompensated heart failure is a predictor of 6-month mortality, independent of N-terminal pro-B-type natriuretic peptide levels: An individual patient data analysis.
    Am Heart J. 2015;170:531-542.
    PubMed     Text format     Abstract available


  39. LUM HD, Jones J, Lahoff D, Allen LA, et al
    Unique challenges of hospice for patients with heart failure: A qualitative study of hospice clinicians.
    Am Heart J. 2015;170:524-530.
    PubMed     Text format     Abstract available


  40. COSTANZO MR, Negoianu D, Fonarow GC, Jaski BE, et al
    Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial.
    Am Heart J. 2015;170:471-82.
    PubMed     Text format     Abstract available


    August 2015
  41. TER MAATEN JM, Dunning AM, Valente MA, Damman K, et al
    Diuretic response in acute heart failure-an analysis from ASCEND-HF.
    Am Heart J. 2015;170:313-321.
    PubMed     Text format     Abstract available


  42. CORRALES-MEDINA VF, Taljaard M, Yende S, Kronmal R, et al
    Intermediate and long-term risk of new-onset heart failure after hospitalization for pneumonia in elderly adults.
    Am Heart J. 2015;170:306-312.
    PubMed     Text format     Abstract available


  43. KELLY JP, Mentz RJ, Hasselblad V, Ezekowitz JA, et al
    Worsening heart failure during hospitalization for acute heart failure: Insights from the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure (ASCEND-HF).
    Am Heart J. 2015;170:298-305.
    PubMed     Text format     Abstract available


  44. KHAZANIE P, Heizer GM, Hasselblad V, Armstrong PW, et al
    Predictors of clinical outcomes in acute decompensated heart failure: Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure outcome models.
    Am Heart J. 2015;170:290-297.
    PubMed     Text format     Abstract available


  45. RUSSO AM, Daugherty SL, Masoudi FA, Wang Y, et al
    Gender and outcomes after primary prevention implantable cardioverter-defibrillator implantation: Findings from the National Cardiovascular Data Registry (NCDR).
    Am Heart J. 2015;170:330-8.
    PubMed     Text format     Abstract available


  46. HEIDENREICH PA, Tsai V, Curtis J, Wang Y, et al
    A validated risk model for 1-year mortality after primary prevention implantable cardioverter defibrillator placement.
    Am Heart J. 2015;170:281-289.
    PubMed     Text format     Abstract available


  47. ZEITLER EP, Al-Khatib SM
    Primary prevention implantable cardioverter defibrillators in women: More questions than answers.
    Am Heart J. 2015;170:197-9.
    PubMed     Text format    


    July 2015
  48. CAPODANNO D, Adamo M, Barbanti M, Giannini C, et al
    Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair.
    Am Heart J. 2015;170:187-95.
    PubMed     Text format     Abstract available


  49. CHRISTODOULIDIS G, Yu J, Kini A, Dangas GD, et al
    Gender-specific outcomes after balloon aortic valvuloplasty: Inhospital and long-term outcomes.
    Am Heart J. 2015;170:180-6.
    PubMed     Text format     Abstract available


  50. DAMLUJI AA, Al-Damluji MS, Marzouka GR, Coffey JO, et al
    New-onset versus prior history of atrial fibrillation: Outcomes from the AFFIRM trial.
    Am Heart J. 2015;170:156-163.
    PubMed     Text format     Abstract available


  51. POKORNEY SD, Simon DN, Thomas L, Fonarow GC, et al
    Patients' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
    Am Heart J. 2015;170:141-148.
    PubMed     Text format     Abstract available


  52. OKRAINEC K, Bell CM, Hollands S, Booth GL, et al
    Risk of cardiovascular events and mortality among a population-based cohort of immigrants and long-term residents with diabetes: Are all immigrants healthier and if so, for how long?
    Am Heart J. 2015;170:123-32.
    PubMed     Text format     Abstract available


    June 2015
  53. KIM KH, Kim HK, Hwang IC, Cho HJ, et al
    PDE 5 inhibition with udenafil improves left ventricular systolic/diastolic functions and exercise capacity in patients with chronic heart failure with reduced ejection fraction; A 12-week, randomized, double-blind, placebo-controlled trial.
    Am Heart J. 2015;169:813-822.
    PubMed     Text format     Abstract available


  54. GRODIN JL, Drazner MH, Dupont M, Mullens W, et al
    A disproportionate elevation in right ventricular filling pressure, in relation to left ventricular filling pressure, is associated with renal impairment and increased mortality in advanced decompensated heart failure.
    Am Heart J. 2015;169:806-12.
    PubMed     Text format     Abstract available


    May 2015
  55. OH J, Kang SM, Song MK, Hong N, et al
    Clinical benefit of spironolactone in patients with acute decompensated heart failure and severe renal dysfunction: Data from the Korean Heart Failure Registry.
    Am Heart J. 2015;169:713-720.
    PubMed     Text format     Abstract available


  56. SCHROTEN NF, Damman K, Hemmelder MH, Voors AA, et al
    Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Hea
    Am Heart J. 2015;169:693-701.
    PubMed     Text format     Abstract available


  57. RUSSO C, Jin Z, Homma S, Rundek T, et al
    Race-ethnic differences in subclinical left ventricular systolic dysfunction by global longitudinal strain: A community-based cohort study.
    Am Heart J. 2015;169:721-6.
    PubMed     Text format     Abstract available


  58. HAHN JY, Yu CW, Park HS, Song YB, et al
    Long-term effects of ischemic postconditioning on clinical outcomes: 1-year follow-up of the POST randomized trial.
    Am Heart J. 2015;169:639-46.
    PubMed     Text format     Abstract available


  59. HOFSTEN DE, Kelbaek H, Helqvist S, Klovgaard L, et al
    The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: Ischemic postconditioning or deferred stent implantation versus conventional primary angioplasty and complete revascularization versus treat
    Am Heart J. 2015;169:613-21.
    PubMed     Text format     Abstract available


    April 2015
  60. STIENEN S, Kok WE
    Response to: Letter to the editor regarding the manuscript "Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-ProBN
    Am Heart J. 2015;169:e5.
    PubMed     Text format    


  61. HU YC, Cao de H, Deng JL
    Letter to the editor regarding the manuscript "Rationale and design of PRIMA II: A multicenter, randomized clinical trial to study the impact of in-hospital guidance for acute decompensated heart failure treatment by a predefined NT-ProBNP target on t
    Am Heart J. 2015;169:e3.
    PubMed     Text format    


  62. GRANGER BB, Ekman I, Hernandez AF, Sawyer T, et al
    Results of the Chronic Heart Failure Intervention to Improve MEdication Adherence study: A randomized intervention in high-risk patients.
    Am Heart J. 2015;169:539-48.
    PubMed     Text format     Abstract available


  63. CORNEL JH, Lopes RD, James S, Stevens SR, et al
    Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial.
    Am Heart J. 2015;169:531-8.
    PubMed     Text format     Abstract available


  64. WHELLAN DJ, Kraus WE, Kitzman DW, Rooney B, et al
    Authorship in a multicenter clinical trial: The Heart Failure-A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION) Authorship and Publication (HAP) Scoring System Results.
    Am Heart J. 2015;169:457-463.
    PubMed     Text format     Abstract available


    March 2015
  65. GANDHI PU, Motiwala SR, Belcher AM, Gaggin HK, et al
    Galectin-3 and mineralocorticoid receptor antagonist use in patients with chronic heart failure due to left ventricular systolic dysfunction.
    Am Heart J. 2015;169:404-411.
    PubMed     Text format     Abstract available


  66. MELGAARD L, Gorst-Rasmussen A, Lip GY, Rasmussen LH, et al
    Female sex is associated with a lower risk of stroke in patients with heart failure.
    Am Heart J. 2015;169:396-403.
    PubMed     Text format     Abstract available


  67. WESSLER JD, Maurer MS, Hummel SL
    Evaluating the safety and efficacy of sodium-restricted/Dietary Approaches to Stop Hypertension diet after acute decompensated heart failure hospitalization: Design and rationale for the Geriatric OUt of hospital Randomized MEal Trial in Heart Failure
    Am Heart J. 2015;169:342-348.
    PubMed     Text format     Abstract available


  68. BUGGEY J, Mentz RJ, Pitt B, Eisenstein EL, et al
    A reappraisal of loop diuretic choice in heart failure patients.
    Am Heart J. 2015;169:323-333.
    PubMed     Text format     Abstract available


  69. BUTLER J, Fonarow GC, O'Connor C, Adams K, et al
    Improving cardiovascular clinical trials conduct in the United States: Recommendation from clinicians, researchers, sponsors, and regulators.
    Am Heart J. 2015;169:305-14.
    PubMed     Text format     Abstract available


    February 2015
  70. PANDEY A, Patel M, Gao A, Willis BL, et al
    Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: The Cooper Center Longitudinal Study.
    Am Heart J. 2015;169:290-297.
    PubMed     Text format     Abstract available


  71. ZIAEIAN B, Sharma PP, Yu TC, Johnson KW, et al
    Factors associated with variations in hospital expenditures for acute heart failure in the United States.
    Am Heart J. 2015;169:282-289.
    PubMed     Text format     Abstract available


  72. COLIN-RAMIREZ E, McAlister FA, Zheng Y, Sharma S, et al
    The long-term effects of dietary sodium restriction on clinical outcomes in patients with heart failure. The SODIUM-HF (Study of Dietary Intervention Under 100 mmol in Heart Failure): A pilot study.
    Am Heart J. 2015;169:274-281.
    PubMed     Text format     Abstract available


  73. ROGERS JG, Boyle AJ, O'Connell JB, Horstmanshof DA, et al
    Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: Design and rationale of the ROADMAP clinical trial.
    Am Heart J. 2015;169:205-210.
    PubMed     Text format     Abstract available


  74. LAVIE CJ, Ventura HO, Milani RV, Arena R, et al
    Critical impact of fitness in the prevention and treatment of heart failure.
    Am Heart J. 2015;169:194-6.
    PubMed     Text format    


    January 2015
  75. MILLS RM, Zhu V, Cody RJ, Yuan Z, et al
    Estimated prevalence of implanted electrophysiologic devices in patients with heart failure.
    Am Heart J. 2015;169:188-9.
    PubMed     Text format    


  76. JOO H, Fang J, Losby JL, Wang G, et al
    Cost of informal caregiving for patients with heart failure.
    Am Heart J. 2015;169:142-148.
    PubMed     Text format     Abstract available


  77. KLIP IT, Postmus D, Voors AA, Brouwers FP, et al
    Hemoglobin levels and new-onset heart failure in the community.
    Am Heart J. 2015;169:94-101.
    PubMed     Text format     Abstract available


  78. STAFINSKI T, Menon D, Nardelli A, Bakal J, et al
    Incorporating patient preferences into clinical trial design: results of the opinions of patients on treatment implications of new studies (OPTIONS) project.
    Am Heart J. 2015;169:122-31.
    PubMed     Text format     Abstract available


  79. TOMEY MI, Mehran R, Brener SJ, Maehara A, et al
    Sex, adverse cardiac events, and infarct size in anterior myocardial infarction: An analysis of Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI).
    Am Heart J. 2015;169:86-93.
    PubMed     Text format     Abstract available


    December 2014
  80. PARK M, Vittinghoff E, Shlipak MG, Mishra R, et al
    Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study.
    Am Heart J. 2014;168:931-939.
    PubMed     Text format     Abstract available


  81. LEVIN SN, Hajduk AM, McManus DD, Darling CE, et al
    Cognitive status in patients hospitalized with acute decompensated heart failure.
    Am Heart J. 2014;168:917-23.
    PubMed     Text format     Abstract available


  82. MENET A, Greffe L, Ennezat PV, Delelis F, et al
    Is mechanical dyssynchrony a therapeutic target in heart failure with preserved ejection fraction?
    Am Heart J. 2014;168:909-916.
    PubMed     Text format     Abstract available


  83. BLECKER S, Ladapo JA, Doran KM, Goldfeld KS, et al
    Emergency department visits for heart failure and subsequent hospitalization or observation unit admission.
    Am Heart J. 2014;168:901-908.
    PubMed     Text format     Abstract available


  84. KRISHNAMOORTHY A, Greiner MA, Sharma PP, DeVore AD, et al
    Transient and persistent worsening renal function during hospitalization for acute heart failure.
    Am Heart J. 2014;168:891-900.
    PubMed     Text format     Abstract available


  85. KOIFMAN E, Grossman E, Elis A, Dicker D, et al
    Multidisciplinary rehabilitation program in recently hospitalized patients with heart failure and preserved ejection fraction: Rationale and design of a randomized controlled trial.
    Am Heart J. 2014;168:830-837.
    PubMed     Text format     Abstract available


    November 2014
  86. CHENG RK, Cox M, Neely ML, Heidenreich PA, et al
    Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Am Heart J. 2014;168:721-730.
    PubMed     Text format     Abstract available


  87. WU WC, Jiang L, Friedmann PD, Trivedi A, et al
    Association between process quality measures for heart failure and mortality among US veterans.
    Am Heart J. 2014;168:713-720.
    PubMed     Text format     Abstract available


  88. MENTZ RJ, Tulsky JA, Granger BB, Anstrom KJ, et al
    The Palliative Care in Heart Failure Trial: Rationale and design.
    Am Heart J. 2014;168:645-651.
    PubMed     Text format     Abstract available


    October 2014
  89. ZABEL M, Muller-Riemenschneider F, Geller JC, Brachmann J, et al
    Rationale and design of the MONITOR-ICD study: A randomized comparison of economic and clinical effects of automatic remote MONITORing versus control in patients with Implantable Cardioverter Defibrillators.
    Am Heart J. 2014;168:430-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: